Park J - Search Results

1

Association of Chemotherapy Response Score with Multidrug Resistance 1 and CA125 ELIMination Rate Constant K in Patients with Advanced Ovarian Cancer Treated with Neoadjuvant Chemotherapy.

Matsukuma K, Nishio S, Tasaki S, Park J, Nasu H, Yoshimitsu T, Tasaki K, Katsuda T, Terada A, Tsuda N, Sanada S, Ushijima K. Matsukuma K, et al. Among authors: park j. Kurume Med J. 2024 Mar 29. doi: 10.2739/kurumemedj.MS7012004. Online ahead of print. Kurume Med J. 2024. PMID: 38556270 Free article.

2

Human papillomavirus genotyping predicts residual/recurrent disease after local treatment for cervical intraepithelial neoplasia better than viral DNA testing.

Kawano K, Tsuda N, Nasu H, Tasaki S, Park J, Tasaki K, Terada A, Nishio S, Ushijima K. Kawano K, et al. Among authors: park j. J Obstet Gynaecol Res. 2021 Oct;47(10):3628-3633. doi: 10.1111/jog.14931. Epub 2021 Jul 12. J Obstet Gynaecol Res. 2021. PMID: 34254407

3

Platinum rechallenge treatment using gemcitabine plus carboplatin with or without bevacizumab for platinum-resistant ovarian cancer.

Nasu H, Nishio S, Park J, Yoshimitsu T, Matsukuma K, Tasaki K, Katsuda T, Terada A, Tsuda N, Ushijima K. Nasu H, et al. Among authors: park j. Int J Clin Oncol. 2022 Apr;27(4):790-801. doi: 10.1007/s10147-021-02103-7. Epub 2022 Jan 5. Int J Clin Oncol. 2022. PMID: 34985551

4

Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601.

Ito K, Nakagawa M, Shimokawa M, Hori K, Tashima L, Goto M, Yanagida S, Suzuki J, Kaya R, Kawabata A, Yamada K, Park J, Nasu H, Nishio S, Kondo E, Kaneda M, Tsubamoto H, Arakawa A, Nagasawa T, Motohashi T. Ito K, et al. Among authors: park j. Anticancer Drugs. 2023 Aug 1;34(7):857-865. doi: 10.1097/CAD.0000000000001472. Epub 2022 Dec 5. Anticancer Drugs. 2023. PMID: 36729915 Clinical Trial.

5

Comprehensive Molecular Profiling and Clinicopathological Characteristics of Gastric-Type Mucinous Carcinoma of the Uterine Cervix in Japanese Women.

Nasu H, Nishio S, Park J, Tasaki K, Terada A, Tsuda N, Kawano K, Kojiro-Sanada S, Akiba J, Ushijima K. Nasu H, et al. Among authors: park j. Kurume Med J. 2024 May 14;69(3.4):237-249. doi: 10.2739/kurumemedj.MS6934018. Epub 2024 Feb 16. Kurume Med J. 2024. PMID: 38369337 Free article.

6

Olaparib maintenance therapy for platinum-sensitive relapsed ovarian cancer at a single institution: A retrospective study.

Katsuda T, Nishio S, Tasaki S, Park J, Tasaki K, Tsuda N, Ushijima K. Katsuda T, et al. Among authors: park j. J Obstet Gynaecol Res. 2024 May 14. doi: 10.1111/jog.15965. Online ahead of print. J Obstet Gynaecol Res. 2024. PMID: 38742699

7

Global and regional burden of vaccine-associated facial paralysis, 1967-2023: Findings from the WHO international pharmacovigilance database.

Jeong YD, Lee K, Lee S, Park J, Kim HJ, Lee J, Kang J, Jacob L, Smith L, Rahmati M, López Sánchez GF, Dragioti E, Son Y, Kim S, Yeo SG, Lee H, Yon DK. Jeong YD, et al. Among authors: park j. J Med Virol. 2024 Jun;96(6):e29682. doi: 10.1002/jmv.29682. J Med Virol. 2024. PMID: 38783823

8

Reconciling conflicting evidence in the evaluation of the MitraClip system: Assessment of and response to the MITRA-FR and COAPT trials by key stakeholders.

Montagnon M, Chen Y, Grove A, Park J, Obadia JF, Armoiry X. Montagnon M, et al. Among authors: park j. J Evid Based Med. 2024 May 24. doi: 10.1111/jebm.12614. Online ahead of print. J Evid Based Med. 2024. PMID: 38783795 No abstract available.

9

Incremental increases in physiological fluid shear progressively alter pathogenic phenotypes and gene expression in multidrug resistant Salmonella.

Yang J, Barrila J, Nauman EA, Nydam SD, Yang S, Park J, Gutierrez-Jensen AD, Castro CL, Ott CM, Buss K, Steel J, Zakrajsek AD, Schuff MM, Nickerson CA. Yang J, et al. Among authors: park j. Gut Microbes. 2024 Jan-Dec;16(1):2357767. doi: 10.1080/19490976.2024.2357767. Epub 2024 May 23. Gut Microbes. 2024. PMID: 38783686

10

Single-cell and spatial transcriptomics analysis of non-small cell lung cancer.

De Zuani M, Xue H, Park JS, Dentro SC, Seferbekova Z, Tessier J, Curras-Alonso S, Hadjipanayis A, Athanasiadis EI, Gerstung M, Bayraktar O, Cvejic A. De Zuani M, et al. Among authors: park js. Nat Commun. 2024 May 23;15(1):4388. doi: 10.1038/s41467-024-48700-8. Nat Commun. 2024. PMID: 38782901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68,470 results

Search Page